CYFLEE LIQUID SYSTEMIC INSECTICIDE FOR CATS

Main information

  • Trade name:
  • CYFLEE LIQUID SYSTEMIC INSECTICIDE FOR CATS
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CYFLEE LIQUID SYSTEMIC INSECTICIDE FOR CATS
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | CAT - QUEEN | CAT - TOM | KITTEN
  • Therapeutic area:
  • PARASITICIDES
  • Therapeutic indications:
  • FLEA | CTENOCEPHALIDES SPP. | GROUND FLEAS

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 35928
  • Last update:
  • 09-08-2016

24-5-2018

FDA Approves Semintra, the First FDA-approved Animal Drug for the Control of Systemic Hypertension in Cats

FDA Approves Semintra, the First FDA-approved Animal Drug for the Control of Systemic Hypertension in Cats

The FDA has approved Semintra (telmisartan oral solution), the first FDA-approved animal drug to control systemic hypertension in cats. Semintra is an oral solution administered either directly into the cat’s mouth or on top of a small amount of food.

FDA - U.S. Food and Drug Administration

There are no news related to this product.